Live Breaking News & Updates on David Risinger Morgan Stanley

Stay updated with breaking news from David risinger morgan stanley. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

ELANCO ANIMAL HEALTH INC (ELAN) Q1 2021 Earnings Call Transcript


ELANCO ANIMAL HEALTH INC (ELAN) Q1 2021 Earnings Call Transcript
Motley Fool Transcribers
© The Motley Fool
Logo of jester cap with thought bubble.
ELANCO ANIMAL HEALTH INC (NYSE: ELAN)
Q1 2021 Earnings Call
Operator
Good day and thank you for standing by. Welcome to the Elanco Animal Health Incorporated Q1 2021 Earnings Conference Call. [Operator Instructions]
I would now like to hand the conference over to your speaker today, Tiffany Kanaga. Please go ahead.SPONSORED:
10 stocks we like better than Elanco Animal Health Inc.
When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade, ....

United States , David Risinger , John Kreger , Jeffrey Simmons , Michael Parolari Raymond James , Raymond James , Erin Wright , Katy Grissom , Tiffany Kanaga , Michael Ryskin , America Merrill Lynch , Todd Young , Dave Urbanek , Jeff Simmons , David Risinger Morgan Stanley , Chris Schott , Michael Parolari , Elliot Wilbur , William Blair , Morgan Stanley , Goldman Sachs , Jonathan Block Stifel Financial Corp , Elanco Animal Health Incorporated , Bayer Animal Health , Erin Wilson Wright Credit Suisse Securities , Motley Fool ,

Jazz Pharmaceuticals PLC (JAZZ) Q1 2021 Earnings Call Transcript


Jazz Pharmaceuticals PLC (JAZZ) Q1 2021 Earnings Call Transcript
Motley Fool Transcribers
© The Motley Fool
Logo of jester cap with thought bubble.
Jazz Pharmaceuticals PLC (NASDAQ: JAZZ)
Q1 2021 Earnings Call
Operator
Welcome to the Jazz Pharmaceuticals PLC First Quarter 2021 Earnings Conference Call. [Operator Instructions] I will now turn the call over to Andrea Flynn, Head Investor Relations at Jazz Pharmaceuticals. Thank you. Please go ahead.SPONSORED:
10 stocks we like better than Jazz Pharmaceuticals
When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade,
Motley Fool Stock Advisor, has tripled the market.   ....

United States , David Risinger , Brucec Cozadd , Gary Nachman , Jason Gerberry , Kim Sablich , Marc Goodman Leerink , Graig Suvannavejh , Balaji Prasad Barclays , Jessica Fye , Anne Borgman , Annabel Samimy , Balaji Prasad , Marc Goodman , David Steinberg , Dan Swisher , Bruce Cozadd , America Merrill Lynch , Annabel Samimy Stifel Nicolaus , Andrean Flynn , Andrea Flynn , Piper Sandler , Gregg Gilbert , Phil Jochelson , David Risinger Morgan Stanley , Esther Rajavelu ,

Repros Therapeutics (RPRX) Q4 2020 Earnings Call Transcript


Repros Therapeutics (RPRX) Q4 2020 Earnings Call Transcript
Motley Fool Transcribing
© The Motley Fool
Logo of jester cap with thought bubble.
Repros Therapeutics (NASDAQ: RPRX)
Ladies and gentlemen, thank you for standing by. Welcome to the Royalty Pharma fourth-quarter 2020 financial results conference call. I would now like to turn the call over to George Grofik, senior vice president, head of investor relations and communications. Please go ahead, sir.
George Grofik
Senior Vice President, Head of Investor Relations and Communications.
Thank you, operator, and good morning and good afternoon to everyone on the call. Thank you for joining us to review Royalty Pharma s fourth-quarter results. You can find the slides of this call on the investors page of our website at royaltypharma.com. Moving to Slide 3. ....

David Risinger , Terence Flynn Goldman Sachs , Jim Reddoch , Terry Coyne , Pablo Legorreta , Terence Flynn , Geoff Meacham , Steve Scala Cowen , Steve Scala , America Merrill Lynch , Mike Difiore , George Grofik , Gregg Gilbert , Mike Difiore Evercore , David Risinger Morgan Stanley , Chris Schott , Gregg Gilbert Truist , Marshall Urist , Morgan Stanley , Head Of Research , Goldman Sachs , Geoff Meacham Bank , Company Analyst , Repros Therapeutics , Motley Fool Repros Therapeutics , Call Transcript ,

Teva Pharmaceutical Industries (TEVA) Q4 2020 Earnings Call Transcript


Operator
Ladies and gentlemen, thank you for standing by. Welcome to today s Teva fourth-quarter and full-year 2020 financial results. [Operator instructions] I must advise you that this conference is being recorded today, Wednesday, the 10th of February 2021. I would now like to hand the conference over to your speaker today, Kevin Mannix, senior vice president, head of investor relations.
Please go ahead, sir.
Senior Vice President, Head of Investor Relations
Thank you, Sharon. And thank you, everyone, for joining us today to discuss Teva s fourth-quarter and full-year 2020 financial results. We hope you ve had an opportunity to review our press release, which was issued one hour ago. A copy of the release, as well as a copy of the slides being presented on this call can be found on our website at www.tevapharm.com. ....

New York , United States , David Risinger , Greg Gilbert , America Merrill Lynch , Greg Gilbert Truist , Raymond James , Teva Europe , Goldman Sachs , Elliot Wilbur Raymond James , Jason Gerberry , Kare Schultz , Kevin Mannix , David Risinger Morgan Stanley , Elliot Wilbur , Brendan Ogrady , Morgan Stanley , Jason Gerberry Bank , Teva Pharmaceutical Industries , Vice President , Eli Kalif , Brendano Grady , North America , Umer Raffat , North American , Ami Fadia ,